{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:29:42Z","timestamp":1793651382244,"version":"4.5.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Primary biliary cholangitis (PBC) is a small-duct cholangiopathy that can lead to end-stage liver disease requiring liver transplantation (LT). Use of donation after circulatory death (DCD) donors in this population has been limited by historic concerns of severe biliary complications and inferior graft outcomes. Recent regulatory approval of normothermic machine perfusion (MP) technology has dramatically improved DCD utilization. However, outcomes of DCD-MP grafts in PBC recipients remain poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We performed a retrospective analysis of adult, first-time, deceased-donor LT recipients with PBC using the Organ Procurement and Transplantation Network registry (2015\u20132025). Recipients were stratified by donation after brain death with cold storage (DBD-CS), DCD-CS, and DCD-MP. Kaplan-Meier and multivariable Cox regression were used to estimate 1-y graft survival and adjusted hazard ratios. Temporal trends were assessed with Poisson regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Among 1604 recipients, 1311 (82%) received DBD-CS, 141 (9%) DCD-CS, and 152 (9%) DCD-MP. DCD groups had lower median Model for End-stage Liver Disease scores (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001) and less dialysis dependence at transplant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001). Donor age was highest for DCD-MP (median 53.5 y;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001). One-year graft survival was similar across groups (DBD-CS 93.0%, DCD-CS 91.0%, DCD-MP 93.3%; log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.76). Adjusted analysis showed no association between donor type and 1-y graft failure (DCD-CS versus DBD-CS adjusted hazard ratio, 1.51; 95% confidence interval, 0.80-2.82;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.2 and DCD-MP versus DBD-CS adjusted hazard ratio, 1.03; 95% confidence interval, 0.49-2.16;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.94). DCD-MP utilization increased 108.9% annually between 2022 and 2025 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>DCD-MP achieved 1-y graft survival comparable to DBD-CS in PBC LT recipients, supporting broader consideration of this strategy. Rapid growth in DCD-MP utilization reflects increasing programmatic confidence in contemporary preservation practices for PBC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000002009","type":"journal-article","created":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:00:40Z","timestamp":1793649640000},"page":"e2009","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Machine-perfused Donation After Circulatory Death Grafts Improve Access to Liver Transplant for Primary Biliary Cholangitis Patients"],"prefix":"10.1097","volume":"12","author":[{"given":"Aaron","family":"Kleinertz","sequence":"first","affiliation":[{"name":"Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayham","family":"Asassfeh","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badi","family":"Rawashdeh","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Battula","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kondragunta Raj","family":"Prasad","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-7287","authenticated-orcid":false,"given":"Siavash","family":"Raigani","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"R1-20261102","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2025.20067","article-title":"Primary biliary cholangitis.","volume":"335","author":"Tana","year":"2026","journal-title":"JAMA"},{"key":"R2-20261102","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2468-1253(25)00025-1","article-title":"Primary biliary cholangitis and the narrowing gap towards optimal disease control.","volume":"10","author":"Can\u00e7ado","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20261102","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis.","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J Hepatol"},{"key":"R4-20261102","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10620-019-05786-1","article-title":"Outcomes of liver transplant candidates with primary biliary cholangitis: the data from the scientific registry of transplant recipients.","volume":"65","author":"Sayiner","year":"2020","journal-title":"Dig Dis Sci"},{"key":"R5-20261102","doi-asserted-by":"crossref","first-page":"100742","DOI":"10.1016\/j.aohep.2022.100742","article-title":"Waitlist mortality in patients with autoimmune liver diseases.","volume":"27","author":"Goyes","year":"2022","journal-title":"Ann Hepatol"},{"key":"R6-20261102","doi-asserted-by":"crossref","first-page":"e14527","DOI":"10.1111\/ctr.14527","article-title":"Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD-Na allocation.","volume":"36","author":"Zhou","year":"2022","journal-title":"Clin Transplant"},{"key":"R7-20261102","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1097\/TP.0000000000004528","article-title":"Biliary complications after liver transplantation in the United States: changing trends and economic implications.","volume":"107","author":"Manay","year":"2023","journal-title":"Transplantation"},{"key":"R8-20261102","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/TP.0000000000005537","article-title":"Embracing liver transplantation from donation after circulatory death in the United States in the era of perfusion technology.","volume":"110","author":"Bekki","year":"2026","journal-title":"Transplantation"},{"key":"R9-20261102","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/01.sla.0000186178.07110.92","article-title":"Donation after cardiac death: the University of Wisconsin experience with liver transplantation.","volume":"242","author":"Foley","year":"2005","journal-title":"Ann Surg"},{"key":"R10-20261102","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1600-6143.2006.01243.x","article-title":"Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN\/UNOS data.","volume":"6","author":"Mateo","year":"2006","journal-title":"Am J Transplant"},{"key":"R11-20261102","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamasurg.2021.6781","article-title":"Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS liver PROTECT randomized clinical trial.","volume":"157","author":"Markmann","year":"2022","journal-title":"JAMA Surg"},{"key":"R12-20261102","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa2031532","article-title":"Hypothermic machine perfusion in liver transplantation\u2014a randomized trial.","volume":"384","author":"Van Rijn","year":"2021","journal-title":"N Engl J Med"},{"key":"R13-20261102","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamasurg.2024.0520","article-title":"US liver transplant outcomes after normothermic regional perfusion vs standard super rapid recovery.","volume":"159","author":"Brubaker","year":"2024","journal-title":"JAMA Surg"},{"key":"R14-20261102","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/ajt.15241","article-title":"In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival.","volume":"19","author":"Watson","year":"2019","journal-title":"Am J Transplant"},{"key":"R15-20261102","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/XCS.0000000000001790","article-title":"Improved outcomes with hypothermic machine perfusion in donation after circulatory death liver transplantation.","volume":"242","author":"Haugen","year":"2026","journal-title":"J Am Coll Surg"},{"key":"R16-20261102","doi-asserted-by":"crossref","first-page":"11729","DOI":"10.3389\/ti.2023.11729","article-title":"Liver transplantation for primary sclerosing cholangitis (PSC) with or without inflammatory bowel disease (IBD)\u2014a European Society of Organ Transplantation (ESOT) consensus statement.","volume":"36","author":"Carbone","year":"2023","journal-title":"Transpl Int"},{"key":"R17-20261102","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.3390\/jcm12206536","article-title":"Two decades of liver transplants for primary biliary cholangitis: a comparative study of living donors vs. deceased donor liver transplantations.","volume":"12","author":"Medina-Morales","year":"2023","journal-title":"J Clin Med"},{"key":"R18-20261102","doi-asserted-by":"crossref","first-page":"e1925","DOI":"10.1097\/TXD.0000000000001925","article-title":"Back-to-base versus in-transit machine perfusion in donation after circulatory death liver transplantation: insights from a national registry.","volume":"12","author":"Alderete","year":"2026","journal-title":"Transplant Direct"},{"key":"R19-20261102","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/jamasurg.2024.6520","article-title":"Improved outcomes and resource use with normothermic machine perfusion in liver transplantation.","volume":"160","author":"Nguyen","year":"2025","journal-title":"JAMA Surg"},{"key":"R20-20261102","doi-asserted-by":"crossref","first-page":"e70133","DOI":"10.1111\/ctr.70133","article-title":"Normothermic machine perfusion improves outcomes for donation after cardiac death allografts with extended donor warm ischemia time.","volume":"39","author":"Li","year":"2025","journal-title":"Clin Transplant"},{"key":"R21-20261102","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/LVT.0000000000000412","article-title":"The impact of normothermic machine perfusion and acuity circles on waitlist time, mortality, and cost in liver transplantation: a multicenter experience.","volume":"31","author":"Wehrle","year":"2025","journal-title":"Liver Transpl"},{"key":"R22-20261102","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/LVT.0000000000000560","article-title":"Transforming the logistics of liver transplantation with normothermic machine perfusion: clinical impact versus cost.","volume":"31","author":"Gao","year":"2025","journal-title":"Liver Transpl"},{"key":"R23-20261102","doi-asserted-by":"crossref","first-page":"e00978","DOI":"10.14309\/ctg.0000000000000978","article-title":"Machine perfusion ameliorates nonanastomotic strictures after liver transplantation: a systematic review and meta-analysis of randomized controlled trials.","volume":"17","author":"Wang","year":"2026","journal-title":"Clin Transl Gastroenterol"},{"key":"R24-20261102","doi-asserted-by":"crossref","first-page":"e70463","DOI":"10.1111\/ctr.70463","article-title":"Normothermic regional perfusion in controlled donation after circulatory death: growing evidence for liver transplantation.","volume":"40","author":"Imai","year":"2026","journal-title":"Clin Transplant"},{"key":"R25-20261102","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/TP.0000000000003476","article-title":"Normothermic ex situ liver perfusion enhances mitochondrial function of DCD grafts as evidenced by high-throughput metabolomics.","volume":"105","author":"Bhat","year":"2021","journal-title":"Transplantation"},{"key":"R26-20261102","doi-asserted-by":"crossref","first-page":"34419","DOI":"10.1038\/s41598-025-17448-6","article-title":"Normothermic machine perfusion converges transplant induced transcript profiles in low and high risk DBD and DCD livers.","volume":"15","author":"Keslar","year":"2025","journal-title":"Sci Rep"},{"key":"R27-20261102","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.30475","article-title":"Normothermic machine perfusion (NMP) inhibits proinflammatory responses in the liver and promotes regeneration.","volume":"70","author":"Jassem","year":"2019","journal-title":"Hepatology"},{"key":"R28-20261102","doi-asserted-by":"crossref","first-page":"G21","DOI":"10.1152\/ajpgi.00266.2021","article-title":"Activation of autophagy during normothermic machine perfusion of discarded livers is associated with improved hepatocellular function.","volume":"322","author":"Ohman","year":"2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R29-20261102","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajt.2025.01.007","article-title":"Normothermic regional and ex situ perfusion reduces postreperfusion syndrome in donation after circulatory death liver transplantation: a retrospective comparative study.","volume":"25","author":"Puttappa","year":"2025","journal-title":"Am J Transplant"},{"key":"R30-20261102","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jgh.12022","article-title":"Vascular biology of the biliary epithelium.","volume":"28","author":"Morell","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R31-20261102","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival.","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"key":"R32-20261102","article-title":"Hepatic ischemia-reperfusion injury: underlying mechanisms and concepts in liver surgery and liver transplantation.","author":"Zhao","journal-title":"Hepatology"},{"key":"R33-20261102","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jss.2025.11.006","article-title":"Noncardiac normothermic regional perfusion in circulatory death donors may improve kidney utilization and prevent delayed graft function.","volume":"317","author":"Endo","year":"2026","journal-title":"J Surg Res"},{"key":"R34-20261102","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3748\/wjg.v29.i20.3066","article-title":"Machine perfusion and the prevention of ischemic type biliary lesions following liver transplant: what is the evidence?","volume":"29","author":"Dur\u00e1n","year":"2023","journal-title":"World J Gastroenterol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TXD.0000000000002009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:00:45Z","timestamp":1793649645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TXD.0000000000002009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000002009","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"2026-04-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}